Pharmacist-Led SDoH Screening Intervention During Transitions of Care in an Acute Care Setting
NCT06802393 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58
Last updated 2025-09-17
Summary
The study is a quasi-experimental pilot study conducted at Buffalo General Medical Center (BGMC). It aims to evaluate the feasibility, acceptability, and effectiveness of a pharmacist-led intervention addressing health-related social needs (HRSN) during transitions of care in the emergency department. The intervention involves: 1) pharmacist led medication review, 2) screening patients using the Accountable Health Communities (AHC) HRSN tool, connecting them to local community-based organizations, and 3) conducting follow-up to assess outcomes. The study will recruit 150 patients (50 intervention and 100 control) and assess healthcare utilization metrics, including hospital readmissions and emergency department visits.
Conditions
- Health Related Social Needs (HRSN)
- Pharmacy
- Medication Reconciliation
Interventions
- OTHER
-
Intervention
The intervention incorporates a multifaceted pharmacist-led approach to addressing health-related social needs (HRSN) during transitions of care in the emergency department (ED) at Buffalo General Medical Center (BGMC). The intervention includes: 1) pharmacist-led medication reconciliation, and 2) HRSN screening using the Accountable Health Communities (AHC) HRSN tool. Based on the results, patients receive tailored referrals to community-based organizations using the 211 WNY database, which provides localized resources aligned with their social needs. Each patient is given a printed handout detailing the referral information. Within one month, a follow-up phone call is conducted to follow up with patients and assess additional needs as well as collect feedback through a patient satisfaction survey.
- OTHER
-
Control
The control arm of the study consists of a historical cohort of patients who were admitted to or discharged from the emergency department (ED) at Buffalo General Medical Center (BGMC) during the same timeframe as the intervention arm but did not receive the pharmacist-led health-related social needs (HRSN) screening or referral intervention. These patients are identified through the electronic health record (EHR) based on the same inclusion criteria as the intervention group, such as age, geographic location, and discharge disposition. Control participants are matched 1:1 with intervention participants using demographic and clinical characteristics, including age (within 5 years), zip code, insurance type, discharge status, and race. Data for the control arm include healthcare utilization metrics such as 30- and 90-day unplanned hospital readmissions and emergency department visits. The control arm serves as a comparator to evaluate the effectiveness of the intervention
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
State University of New York at Buffalo
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-01
- Primary Completion
- 2025-07-15
- Completion
- 2025-09-15
Countries
- United States
Study Locations
More Related Trials
-
Clinical Pharmacist Impact Study
NCT07269002 ·Status: COMPLETED ·Phase: NA
-
Pharmacy Home Adherence Reporting and Monitoring Outcomes Study
NCT02306122 ·Status: COMPLETED ·Phase: NA
-
A Pharmacist-led Transitions of Care Program
NCT04556786 ·Status: COMPLETED ·Phase: NA
-
Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice
NCT01351441 ·Status: COMPLETED ·Phase: NA
-
Enhancing Timely Access to Medication Changes: The Role of Pharmacists in Overcoming Transitions of Care Challenges
NCT07018232 ·Status: COMPLETED
-
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
NCT02215408 ·Status: COMPLETED ·Phase: NA
-
Medication Histories Conducted by Nurses (RNs), Pharmacy Techs (CPhTs) & Pharmacists (RPhs)
NCT01065675 ·Status: TERMINATED ·Phase: NA
-
Exploratory Study to Inventory Opportunities to Optimize Continuity of Pharmacotherapy at Hospital Discharge
NCT03223584 ·Status: COMPLETED
-
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
NCT00632021 ·Status: COMPLETED ·Phase: NA
-
the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes
NCT01906710 ·Status: UNKNOWN ·Phase: NA
-
Clinical Pharmacist Intervention to Reduce Drug-related Readmissions Among Older People
NCT03671629 ·Status: RECRUITING ·Phase: NA
-
Improving Safety After Hospitalization in Older Persons on High-Risk Medications
NCT02781662 ·Status: COMPLETED ·Phase: NA
-
Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
NCT02026453 ·Status: COMPLETED ·Phase: NA
-
A Trial to De-prescribe Inappropriate Medications in the Community Dwelling Elderly
NCT02053194 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
NCT06374277 ·Status: RECRUITING ·Phase: NA
-
Vascular Lifestyle-Intervention and Screening in Pharmacy
NCT02223793 ·Status: UNKNOWN ·Phase: NA
-
Trial of a Pharmacist-physician Intervention Model to Reduce High-risk Drug Use by Hospitalised Elderly Patients
NCT02570945 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence
NCT02031406 ·Status: TERMINATED ·Phase: NA
-
Improving Safety By Computerizing Outpatient Prescribing
NCT00235027 ·Status: COMPLETED ·Phase: NA
-
Oslo Pharmacist Intervention Study - Effect on Readmissions
NCT02336113 ·Status: UNKNOWN ·Phase: NA
-
Feasibility Study of the Medication Review With Follow up Service for Patients With Polypharmacy in Swiss Community Pharmacies
NCT05348538 ·Status: UNKNOWN ·Phase: NA
-
The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You
NCT03079375 ·Status: COMPLETED ·Phase: NA
-
Pharmacist-led Intervention on Hemodialysis Patients' Therapy Adherence
NCT06744738 ·Status: COMPLETED ·Phase: NA
-
Patient Pathway Pharmacist - Optimal Drug-related Care
NCT03695081 ·Status: COMPLETED ·Phase: NA
-
Iatrogenic Drug Risk in People Over 75, With or Without Cognitive Disorders, From an Inventory of Their Family Pharmacy
NCT03686943 ·Status: WITHDRAWN